SIR-2.3/SIRT4 loss enhances proteostasis and neuronal resilience via AMPK-induced autophagy in Huntington’s disease models
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Koyuncu, S.
- Gómez-Escribano, A.P.
- Mora, C.
- Néri, C.
- Dos Ramos, Y.
- Vílchez, D.
Grupos
Abstract
Huntington’s disease (HD) is a neurodegenerative disorder caused by mutations in the huntingtin gene resulting in an extended polyglutamine (polyQ) stretch in the protein, which is prone to aggregation and toxicity. In addition to a proteostasis imbalance, growing evidence highlights the role of mitochondrial dysfunction in HD progression. Here we explore the role of SIR-2.3/SIRT4, a mitochondrial sirtuin, in polyQ-expanded peptides and mutant huntingtin (mHTT) toxicity using C. elegans and mammalian models. Notably, loss of sir-2.3 function results in neuronal protection mediated by AMPK activation and enhanced autophagy. These neuroprotective effects require the transcription factors DAF-16/FOXO and NHR-49, which regulate autophagy and metabolism. To explore the translational potential of these findings, we used soft ATP synthase inhibitors to mimic sir-2.3 ablation, successfully reducing mHTT-induced neuronal toxicity. These results identify the SIRT4-AMPK axis as a critical regulator linking mitochondrial metabolism, autophagy, and neuronal homeostasis in HD. These findings not only advance our understanding of HD pathogenesis but also offer promising therapeutic targets for restoring proteostasis and neuronal resilience capacity against neurodegenerative diseases. © The Author(s) 2026.
Datos de la publicación
- ISSN/ISSNe:
- 1478-811X, 1478-811X
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 41535947
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,710 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Cell Communication and Signaling BMC
Citas Recibidas en Web of Science: 1
Documentos
- No hay documentos
Filiaciones
Keywords
- huntingtin; polyglutamine; proton transporting adenosine triphosphate synthase; sirtuin; transcription factor; adult; animal cell; animal experiment; animal model; animal tissue; article; autophagy (cellular); Caenorhabditis elegans; controlled study; human; human cell; Huntington chorea; mitochondrial respiration; mouse; nerve cell; neuroprotection; neurotoxicity; nonhuman; protein homeostasis
Proyectos y Estudios Clínicos
MODFAT-HD-Modulators of fat metabolism as druggable targets to treat Huntington Disease.
Investigador Principal: RAFAEL VÁZQUEZ MANRIQUE
PCI2021-122099-2B . COMISION EUROPEA . 2022
Cita
TRUJILLO C,Koyuncu S,TORTAJADA J,COLLADO M,Gómez AP,Mora C,Néri C,LAHOZ A,ROCA M,MILLÁN JM,Dos Y,Vílchez D,CARRANZA A,VÁZQUEZ RP. SIR-2.3/SIRT4 loss enhances proteostasis and neuronal resilience via AMPK-induced autophagy in Huntington’s disease models. Cell Commun. Signal. 2026. 24. (1):109. IF:11,600. (1).
Portal de investigación